A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Multiple Doses of CG5503 Immediate-Release Formulation in the Treatment of Acute Pain From Bunionectomy Followed by a Voluntary Open-Label Extension.
Latest Information Update: 02 Jul 2009
At a glance
- Drugs Tapentadol (Primary) ; Oxycodone
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 10 May 2008 Results were presented at the 27th Annual Scientific Meeting of the American Pain Society.
- 12 Nov 2006 New trial record.